Advertisement
Clinical Investigation| Volume 356, ISSUE 4, P374-381, October 2018

The Acute Effects of Cigarette Smoking on the Functional State of High Density Lipoprotein

  • Author Footnotes
    # The first two authors (S-QS and HC) contributed equally to this work.
    Si-Qi Shen
    Footnotes
    # The first two authors (S-QS and HC) contributed equally to this work.
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Author Footnotes
    # The first two authors (S-QS and HC) contributed equally to this work.
    Hui Chang
    Footnotes
    # The first two authors (S-QS and HC) contributed equally to this work.
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Zi-Xi Wang
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Hong-Ying Chen
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Lian-Feng Chen
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Feng Gao
    Affiliations
    SINOPEC Lubricant Company Yanshan Branch, Beijing, PR China
    Search for articles by this author
  • Xiao-Wei Yan
    Correspondence
    Correspondence: Xiao-Wei Yan, MD, PhD, Department of Cardiology, Peking Union Medical College, PUMC and Chinese Academy of Medical Sciences, Beijing 100730, PR China.
    Affiliations
    Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, PR China
    Search for articles by this author
  • Author Footnotes
    # The first two authors (S-QS and HC) contributed equally to this work.

      Abstract

      Background

      Cigarette smoking disturbs plasma lipid level and lipoprotein metabolism; however, the effects of smoking on the functional state of high density lipoprotein (HDL) are still not clear. This study aimed to determine the antioxidant and antichemotactic properties of HDL and HDL-mediated cholesterol efflux in healthy subjects after cigarette smoking.

      Materials and Methods

      Healthy male subjects, including nonsmokers (n = 16) and chronic smokers (n = 8), were enrolled. After smoking 8 cigarettes within 2 hours, plasma HDL was isolated and tested. Copper-induced low density lipoprotein (LDL) oxidation was used to determine the antioxidant ability of HDL. The concentration of serum amyloid A was measured by Enzyme Linked Immunosorbent Assay. Chemotaxis was detected by transwell assay. HDL-mediated cholesterol efflux was measured using fluorescent cholesterol analog.

      Results

      LDL baseline oxidation state was higher in chronic smokers than that in nonsmokers. Meanwhile, HDL-induced cholesterol efflux in macrophages in chronic smokers was significantly enhanced compared with that in nonsmokers. After acute smoking, both the antioxidant and antichemotactic ability of HDL declined in nonsmokers. However, in healthy chronic smokers, the effect of HDL on the susceptibility of LDL to oxidation was compensatorily enhanced. Nevertheless, their bodies were still in a higher oxidation state. Also, acute smoking did not affect HDL-mediated cholesterol efflux significantly in both nonsmokers and chronic smokers.

      Conclusions

      Our data suggest that acute smoking attenuates the antioxidant and antichemotactic abilities of HDL in nonsmokers. Chronic smokers are in a higher oxidative state, although the antioxidant function of their HDL is compensatorily enhanced.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Gordon T
        • Castelli WP
        • Hjortland MC
        • et al.
        High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.
        Am J Med. 1977; 62: 707-714
        • Majeed F
        • Miller M
        Low high-density lipoprotein cholesterol: an important consideration in coronary heart disease risk assessment.
        Curr Opin Endocrinol Diabetes Obes. 2008; 15: 175-181
        • Argraves KM
        • Argraves WS
        HDL serves as a S1P signaling platform mediating a multitude of cardiovascular effects.
        J Lipid Res. 2007; 48: 2325-2333
        • Keul P
        • Sattler K
        • Levkau B
        HDL and its sphingosine-1-phosphate content in cardioprotection.
        Heart Fail Rev. 2007; 12: 301-306
        • Nofer JR
        • Assmann G
        Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids.
        Trends Cardiovasc Med. 2005; 15: 265-271
        • Nofer JR
        • Kehrel B
        • Fobker M
        • et al.
        HDL and arteriosclerosis: beyond reverse cholesterol transport.
        Atherosclerosis. 2002; 161: 1-16
        • Okajima F.
        Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator?.
        Biochim Biophys Acta. 2002; 1582: 132-137
        • Gabay C
        • Kushner I
        Acute-phase proteins and other systemic responses to inflammation.
        New Engl J Med. 1999; 340: 448-454
        • Navab M
        • Ananthramaiah GM
        • Reddy ST
        • et al.
        The double jeopardy of HDL.
        Ann Med. 2005; 37: 173-178
        • Duffy D
        • Rader DJ
        Update on strategies to increase HDL quantity and function.
        Nat Rev Cardiol. 2009; 6: 455-463
        • Navab M
        • Reddy ST
        • Van Lenten BJ
        • et al.
        The role of dysfunctional HDL in atherosclerosis.
        J Lipid Res. 2009; 50: S145-S149
        • Ambrose JA
        • Barua RS
        The pathophysiology of cigarette smoking and cardiovascular disease: an update.
        J Am Coll Cardiol. 2004; 43: 1731-1737
        • Coetzee GA
        • Strachan AF
        • van der Westhuyzen DR
        • et al.
        Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.
        J Biol Chem. 1986; 261: 9644-9651
        • Loura LM
        • Fedorov A
        • Prieto M
        Exclusion of a cholesterol analog from the cholesterol-rich phase in model membranes.
        Biochim Biophys Acta. 2001; 1511: 236-243
        • He RL
        • Zhou J
        • Hanson CZ
        • et al.
        Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2.
        Blood. 2009; 113: 429-437
        • Goodyear MD
        • Krleza-Jeric K
        • Lemmens T
        The Declaration of Helsinki.
        BMJ (Clinical Research ed.). 2007; 335: 624-625
        • Alonso JR
        • Cardellach F
        • Casademont J
        • et al.
        Reversible inhibition of mitochondrial complex IV activity in PBMC following acute smoking.
        Eur Respir J. 2004; 23: 214-218
        • van der Vaart H
        • Postma DS
        • Timens W
        • et al.
        Acute effects of cigarette smoke on inflammation and oxidative stress: a review.
        Thorax. 2004; 59: 713-721
        • Karlsson H
        • Leanderson P
        • Tagesson C
        • et al.
        Lipoproteomics II: mapping of proteins in high-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry.
        Proteomics. 2005; 5: 1431-1445
        • Lowry OH
        • Rosebrough NJ
        • Farr AL
        • et al.
        Protein measurement with the Folin phenol reagent.
        J Biol Chem. 1951; 193: 265-275
      1. Wang X, Yang Z, Xue B, et al. Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology. 152:836-846.

        • Esterbauer H
        • Striegl G
        • Puhl H
        • et al.
        Continuous monitoring of in vitro oxidation of human low density lipoprotein.
        Free Rad Res Commun. 1989; 6: 67-75
        • McEneny J
        • McKavanagh P
        • York E
        • et al.
        Serum- and HDL3-serum amyloid A and HDL3-LCAT activity are influenced by increased CVD-burden.
        Atherosclerosis. 2016; 244: 172-178
        • Kintscher U
        • Goetze S
        • Wakino S
        • et al.
        Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
        Eur J Pharmacol. 2000; 401: 259-270
        • Song W
        • Wang W
        • Dou LY
        • et al.
        The implication of cigarette smoking and cessation on macrophage cholesterol efflux in coronary artery disease patients.
        J Lipid Res. 2015; 56: 682-691
        • Abboud RT
        • Fera T
        • Johal S
        • et al.
        Effect of smoking on plasma neutrophil elastase levels.
        J Lab Clin Med. 1986; 108: 294-300
        • Mayer M
        Association of serum bilirubin concentration with risk of coronary artery disease.
        Clin Chem. 2000; 46: 1723-1727
        • Stocker R
        • Yamamoto Y
        • McDonagh AF
        • et al.
        Bilirubin is an antioxidant of possible physiological importance.
        Science (New York, NY). 1987; 235: 1043-1046
        • Stalenhoef AF
        • de Graaf J
        • Wittekoek ME
        • et al.
        The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
        Atherosclerosis. 2000; 153: 129-138
        • Badolato R
        • Wang JM
        • Murphy WJ
        • et al.
        Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes.
        J Exp Med. 1994; 180: 203-209
        • Storey SM
        • Atshaves BP
        • McIntosh AL
        • et al.
        Effect of sterol carrier protein-2 gene ablation on HDL-mediated cholesterol efflux from cultured primary mouse hepatocytes.
        Am J Physiol Gastrointest Liver Physiol. 2010; 299: G244-G254
        • Jeong YH
        • Cho JH
        • Kang MK
        • et al.
        Smoking at least 10 cigarettes per day increases platelet inhibition by clopidogrel in patients with ST-segment-elevation myocardial infarction.
        Thromb Res. 2010; 126: e334-e338
        • Tuzun B
        • Wolf R
        • Tuzun Y
        • et al.
        Recurrent aphthous stomatitis and smoking.
        Int J Dermatol. 2000; 39: 358-360
        • de Lau LM
        • Breteler MM
        Epidemiology of Parkinson's disease.
        Lancet Neurol. 2006; 5: 525-535